Non-alcoholic fatty liver disease: when to intervene and with what

Nwe Ni Than, Philip N Newsome

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Non-alcoholic fatty liver disease (NAFLD) is increasingly common due to the rising prevalence of obesity in both children and adults. It is associated with metabolic risk factors such as diabetes mellitus, dyslipidaemia and hypertension, and is associated with increased mortality both from cardiovascular-related and liver-related deaths. Identification of those individuals with significant inflammation and fibrosis is a critical part of the patient pathway. Current treatments for NAFLD include weight loss from lifestyle modification or bariatric surgery, management of underlying metabolic risk factors and for those with end stage liver disease, liver transplantation.

Original languageEnglish
Pages (from-to)186-190
Number of pages5
JournalClinical Medicine
Issue number2
Publication statusPublished - Apr 2015

Bibliographical note

© 2015 Royal College of Physicians.


Dive into the research topics of 'Non-alcoholic fatty liver disease: when to intervene and with what'. Together they form a unique fingerprint.

Cite this